Nanologica AB (publ)
STO:NICA
Relative Value
The Relative Value of one NICA stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.409 SEK, Nanologica AB (publ) is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
NICA Competitors Multiples
Nanologica AB (publ) Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
N
|
Nanologica AB (publ)
STO:NICA
|
36.1m SEK | 1.6 | -0.8 | -0.9 | -0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
400.6B USD | 6.6 | 168.8 | 16.4 | 23.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189B USD | 6.4 | 22.2 | 15.1 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.3B USD | 9.9 | 30.1 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD | 5.8 | 18.4 | 14 | 15.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.6B AUD | 3.3 | 17.3 | 11.8 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.2B EUR | 14.5 | 34 | 58.5 | 60.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |